Edwards Lifesciences Corp
F:EWL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Edwards Lifesciences Corp
F:EWL
|
US |
|
Opthea Ltd
F:UKJ
|
AU |
|
A
|
Accenture PLC
XMUN:CSA
|
IE |
|
Bio-Techne Corp
NASDAQ:TECH
|
US |
Wall St Price Targets
EWL Price Targets Summary
Edwards Lifesciences Corp
According to Wall Street analysts, the average 1-year price target for EWL is 88.33 EUR with a low forecast of 74.47 EUR and a high forecast of 100.19 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EWL's stock price target?
Price Target
88.33
EUR
According to Wall Street analysts, the average 1-year price target for EWL is 88.33 EUR with a low forecast of 74.47 EUR and a high forecast of 100.19 EUR.
What is the Revenue forecast for Edwards Lifesciences Corp?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 5 years is 10%.
What is the Gross Profit forecast for Edwards Lifesciences Corp?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 5 years is 10%.
What is the Operating Income forecast for Edwards Lifesciences Corp?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 5 years is 13%.
What is the Pre-Tax Income forecast for Edwards Lifesciences Corp?
Projected CAGR
28%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 28%.
What is the Net Income forecast for Edwards Lifesciences Corp?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 5 years is 20%.
